Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-12 @ 10:06 PM
Study NCT ID:
NCT02304393
Status:
COMPLETED
Last Update Posted:
2019-12-13
First Post:
2014-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-26
First Submit QC Date:
None
Study First Post Date:
2014-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-11
Last Update Post Date:
2019-12-13
Last Update Post Date Type:
ACTUAL